<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03371524</url>
  </required_header>
  <id_info>
    <org_study_id>ARYEL</org_study_id>
    <nct_id>NCT03371524</nct_id>
  </id_info>
  <brief_title>A Prospective RegistrY of Cardiac Echographic Loops</brief_title>
  <acronym>ARYEL</acronym>
  <official_title>A Prospective RegistrY of Cardiac Echographic Loops</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardiawave SA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cardiawave SA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      CARDIAWAVE, a French start-up founded in 2014, aims to develop a new non-invasive therapy to
      treat patients suffering from Aortic Valve Stenosis (AS) who are not candidates to validated
      treatment of AS, i.e. TAVI (Transcatheter Aortic Valve Implantation) or SAVR (Surgical Aortic
      Valve Replacement). This therapy consists in focusing ultrasound on aortic valve
      transthoracically and use high energy to soften calcification from the target valve. In order
      to do so, we develop a device able to deliver high energy ultrasounds to a targeted valve
      thanks to the synchronization of patient hearts live imaging and therapy in real time.

      Live imaging will use an algorithm to realize 'valve tracking': an automatic detection of
      aortic valve position and shape as fast as image acquisition time. In order to develop and
      validate this 'valve tracking' algorithm, CARDIAWAVE requires cardiac echographic loops of
      patients with aortic valve calcification, with 30 seconds or 60 seconds recording.

      The objective of the present study is to develop and validate the 'valve tracking' processing
      algorithm of CARDIAWAVE.

      ARYEL is a prospective, multicenter, non-interventional study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 19, 2017</start_date>
  <completion_date type="Actual">February 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Validation of the 'valve tracking' processing algorithm of CARDIAWAVE.</measure>
    <time_frame>Through study completion, up to 6 months</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Calcified Aortic Valve</condition>
  <arm_group>
    <arm_group_label>Native valves_30 seconds loops</arm_group_label>
    <description>Patient with calcified aortic stenosis on native valve: record of a 30 second loop during routine cardiac echography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Native valves_30 and 60 seconds loops</arm_group_label>
    <description>Patient with calcified aortic stenosis on native valve: record of a 30 second loop and a 60 second loop during routine cardiac echography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bioprosthesis_30 seconds loops</arm_group_label>
    <description>Patient with calcified aortic stenosis on bioprosthesis: record of a 30 second loop during routine cardiac echography.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac Echography</intervention_name>
    <description>While routine cardiac echography is performed on patients with calcified aortic valve, a 30 second loop is recorded.</description>
    <arm_group_label>Bioprosthesis_30 seconds loops</arm_group_label>
    <arm_group_label>Native valves_30 and 60 seconds loops</arm_group_label>
    <arm_group_label>Native valves_30 seconds loops</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosed calcified aortic stenosis.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged ≥ 18 y.o

          -  Patients with a confirmed diagnosis of Aortic valve calcification on native valve or
             bioprosthesis

          -  Patients with planned cardiac transthoracic echography for 'Aortic valve
             calcification' follow-up

          -  Patients who have signed Informed Consent Form

          -  Patients affiliated to French social security or equivalent

        Exclusion Criteria:

          -  Patients allergic to echographic gel

          -  Patients with &quot;hostile thorax&quot;: serious cutaneous irradiation injury or major thoracic
             deformity.

          -  Low echogenicity

          -  Patients with mild or high abundance pericardic effusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>December 7, 2017</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>March 18, 2019</last_update_submitted>
  <last_update_submitted_qc>March 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

